Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
---|
02/17/2011 | US20110039467 Ionic liquid flame retardants |
02/17/2011 | US20110039109 Activator for epoxy resin compositions |
02/16/2011 | EP2284179A2 Inhibitors of cancer cell, T-cell and keratinocyte proliferation |
02/16/2011 | EP2284178A2 Inhibitors of cancer cell, T-cell and keratinocyte proliferation |
02/16/2011 | EP1663105B1 Cycloalkyl heterocycles for treating hepatitis c virus |
02/16/2011 | EP1615866B1 Indene derivatives as pharmaceutical agents |
02/16/2011 | EP1379498B1 Sulphones which modulate the action of gamma secretase |
02/16/2011 | CN101973941A Method for preparing 4-hydroxyphenyl hydantoin |
02/16/2011 | CN101973940A Continuously synthesizing method of sulfonic acid alkyl group ionic liquid |
02/16/2011 | CN101973829A Trifluoromethylation of trifluoromethyl aryl sulfonium salt to heterocyclic compound under metal trigger |
02/16/2011 | CN101659641B Preparation method of L-carnosine zinc |
02/16/2011 | CN101560189B Metronidazole and compound for substituting salicylic acid and preparation method and application thereof |
02/15/2011 | US7888516 transforming growth factor (TGF- beta ) gene expression inhibitors comprising a pyrrole-imidazole polyamides, used as a therapeutic agent for diseases associated with the production of TGF- beta; drugs; side effect reduction |
02/15/2011 | US7888515 Method for the production of N,N-carbonyldiazoles |
02/15/2011 | US7888351 Organic compounds |
02/15/2011 | CA2478156C Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
02/10/2011 | WO2011016559A1 Heterocyclic compound and use thereof |
02/10/2011 | WO2011016523A1 Process for production of bis-quaternary ammonium salt, and novel intermediate |
02/10/2011 | WO2011016501A1 Prophylactic or therapeutic agent for cancer |
02/10/2011 | US20110034525 Nonsedating alpha-2 agonists |
02/10/2011 | US20110034518 Pharmaceutical composition |
02/10/2011 | US20110034513 Heterocyclic Sulfonamide Inhibitors of Beta Amyloid Production |
02/10/2011 | US20110034483 2-aminoimidazole beta-secretase inhibitors for the treatment of alzheimer's disease |
02/10/2011 | US20110034463 Type iii secretion inhibitors, analogs and uses thereof |
02/10/2011 | US20110033647 Novel ionic liquids, functionalized particulates, and fluoropolymer composites |
02/09/2011 | EP2281817A1 Substituted carbinol compound having cyclic linker |
02/09/2011 | EP2281812A1 Nitrogenous heterocyclic compound with insecticidal activity and its preparation and use |
02/09/2011 | EP2280706A1 Lipoprotein lipase-activating compositions comprising benzene derivates |
02/09/2011 | EP1644321B1 New benzamides as ppaty modulators |
02/09/2011 | EP1379508B9 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof |
02/09/2011 | CN101970414A 1 ibeta-hydroxysteroid dehydrogenase inhibitors |
02/09/2011 | CN101967126A Chiral leucine ion liquid |
02/08/2011 | US7884212 deprotection of triphenylmethane(trityl)of 1-[[cyclohexyloxy) carbonyl]oxy]-ethyl-2-ethoxy-1-[[2'-(N-triphenyl-methyltetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (trityl candesartan cilexetil) in methanol and in the presence of ZnCl2 |
02/08/2011 | US7884121 Process for the preparation of phenylcarbamates |
02/08/2011 | US7884120 microbiocides such as 2-(2-methyl-1H-indol-3-yl)-3a,11b-dihydro-1H-phenanthro[9,10-d]imidazole; bactericides; fungicides |
02/08/2011 | US7884103 such as N-(4-Chloro-phenyl)-2-methyl-2-phenylmethanesulfonylamino-3-(4-[1,2,4]triazol-1-yl-phenoxy)-propionamide, used for controlling or preventing the infestation of plants by phytopathogenic microorganisms, especially fungi |
02/08/2011 | CA2598156C Phosphonium and imidazolium salts and methods of their preparation |
02/08/2011 | CA2446924C 2-iminopyrrolidine derivatives |
02/03/2011 | WO2011014613A2 Preparation of fipamezole |
02/03/2011 | WO2011011965A1 Luteinising hormone releasing hormone antagonist with hydantoin structure |
02/03/2011 | US20110028733 Process for the preparation of 5-(2-ethyl-dihydro-1h-inden-2-yl)-1h-imidazole and salts thereof |
02/03/2011 | US20110028489 Pyrimidine Derivatives and Their Use for Treating Bone-Related Disorders |
02/03/2011 | US20110028468 Compounds having npy y5 receptor antagonistic activity |
02/03/2011 | US20110028446 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
02/03/2011 | DE102009035810A1 Device for the provision of a hydraulic consumer of a vehicle equipped with an armor having fluid standing under pressure for military purposes, comprises a pressure conveying device, and a prestressing unit |
02/02/2011 | EP2279192A2 Ionic liquids |
02/02/2011 | EP2279176A1 Novel imidazole derivatives having microbiocidal activity |
02/02/2011 | EP2279172A2 Use of ionic liquids with tetracyanoborate anions as a solvent for extraction of alcohols from aqueous solutions |
02/02/2011 | EP2278878A1 2-aryl glycinamide derivatives |
02/02/2011 | EP1020179B9 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition |
02/02/2011 | CN1802715B Electrolytic solution for electrochemical element, method of searching for the same, method of producing the same, and electrochemical element |
02/02/2011 | CN101962366A Diphenyl thioether linked bis-imidazoline ligand compound and preparation method thereof |
02/02/2011 | CN101195570B Salt amino acid of ferulic acid |
02/01/2011 | US7880017 Process for the synthesis of imidazoles |
02/01/2011 | US7880009 Cinnamide compound |
02/01/2011 | US7879896 Dual-acting imidazole antihypertensive agents |
02/01/2011 | US7879886 such as N-benzyl-N-hydroxy-2-(3-hydoxypyridin-2-ene)-1,3-thiazolidine-4-carboxamide, used for reducing the population of Plasmodium in a human infested with Plasmodium protozoans and suffering from malaria |
02/01/2011 | US7879863 Aniline derivatives |
02/01/2011 | CA2555633C Non-nucleoside reverse transcriptase inhibitors |
02/01/2011 | CA2502633C 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives |
01/27/2011 | WO2011010619A1 Diamine compound, polyamic acid, polyimide, and liquid crystal aligning agent |
01/27/2011 | US20110021573 Antagonists of prostaglandin d2 receptors |
01/27/2011 | US20110021448 Inhibitors for the Soluble Epoxide Hydrolase |
01/26/2011 | EP2277848A1 Indene derivatives as pharmaceutical agents |
01/26/2011 | EP2276745A1 Ruthenium olefin metathesis catalysts bearing n-heterocyclic carbene ligands with substituted backbone |
01/26/2011 | EP1675833B1 1h-imidazole derivatives as cannabinoid receptor modulators |
01/26/2011 | EP1554239B1 Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists |
01/26/2011 | CN101959882A 咪唑羰基化合物 Imidazole-carbonyl compound |
01/26/2011 | CN101959803A Method for water purification, equipment for water purification, and water purification set |
01/26/2011 | CN101955768A Surfactant used for displacement of reservoir oil, preparation method and application thereof in tertiary oil recovery |
01/26/2011 | CN101955462A Fenticonazole nitrate, preparation of levorotatory form and dextrorotatory form and application of levorotatory form in preparing antifungal medicaments |
01/26/2011 | CN101239951B 1-(2,3-dihydroxypropyl)-2-methyl-5-nitroimidazole compound and its preparation method and use |
01/25/2011 | US7875645 2-(2-cyclopropyl-benzyl)-4,5-dihydro-1H-imidazole; depression, anxiety disorders, bipolar disorder, attention deficit hyperactivity disorder, stress-related disorders, psychotic disorders such as schizophrenia, neurological diseases such as Parkinson's disease, neurodegenerative disorders |
01/25/2011 | US7875631 e.g.1-(3,5-dichlorophenyl)-2-formyl-6-methoxy-1,2,3,4-tetrahydroisoquinoline; to prevent and/or treat cancer and other abnormal cell growth, and metabolic as well as blood vessel proliferate disorders, in which uncontrolled expression of insulin-like growth factor-1 receptor is observed |
01/25/2011 | CA2589329C Composition for controlling harmful bio-organisms and method for controlling harmful bio-organisms using the same |
01/25/2011 | CA2404125C Sulphonamido-substituted bridged bicycloalkyl derivatives |
01/20/2011 | WO2011007899A1 Glycine transporter inhibitors |
01/20/2011 | WO2011007819A1 Pharmaceutical product containing lactam or benzene sulfonamide compound |
01/20/2011 | WO2011006903A1 Substituted triazole and imidazole derivatives as gamma secretase modulators |
01/20/2011 | WO2010120370A3 Gamma-amino-butyric acid derivatives as gabab receptor ligands |
01/20/2011 | US20110015389 1,3 imidazolidine derivatives and their use in the production of carbapenem |
01/20/2011 | US20110015371 Inhibitors of interleukin-1 beta converting enzyme |
01/20/2011 | US20110015360 Dithiocarbamic esters |
01/20/2011 | US20110015246 Lofexidine enantiomers for use as a treatment for cns disease and pathologies and its chiral synthesis |
01/20/2011 | CA2778517A1 Substituted triazole and imidazole derivatives as gamma secretase modulators |
01/19/2011 | EP2275411A2 Reformatsky Reagent in Stable Form and Process for Producing the Same |
01/19/2011 | EP2275395A2 Copper-catalyzed formation of carbon-carbon bonds |
01/19/2011 | EP2274287A1 Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 |
01/19/2011 | EP2274284A2 Fungicidal substituted azoles |
01/19/2011 | CN201711151U Metronidazole hydroxylation reaction kettle |
01/19/2011 | CN101948435A Preparation method of 5-chlorine-1-methyl-4-nitro iminazole |
01/19/2011 | CN101948434A Chiral tyrosine radical ionic liquid |
01/19/2011 | CN101193866B Process for the synthesis of 5- (methyl-1H-imidazol-1-yl) -3- (trifluoromethyl) -benzeneamine |
01/19/2011 | CN101052638B 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
01/18/2011 | US7872139 Heteroaryl-ureas and their use as glucokinase activators |
01/18/2011 | US7871960 1-(Imidazolin-2-yl)amino-1,2-diphenylethane compounds for combating animal pests |
01/18/2011 | CA2500964C Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
01/13/2011 | WO2011005969A2 Etomidate analogues that do not inhibit adrenocortical steroid synthesis |
01/13/2011 | WO2011005959A1 Process for the preparation of n-protected-decylaminoethanal |
01/13/2011 | WO2011004384A2 Process for the preparation of eprosartan |